AQXP - Aquinox Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Aquinox Pharmaceuticals, Inc.

887 Great Northern Way
Suite 450
Vancouver, BC V5T 4T5

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees8

Key Executives

NameTitlePayExercisedYear Born
Mr. David J. MainCo-Founder, Chairman, Pres & CEO812.64kN/A1965
Mr. Kamran AlamCFO, VP of Fin. & Corp. Sec.492.75kN/A1974
Ms. Shelley McCloskeyVP of HR & Admin.N/AN/A1960
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aquinox Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering and developing therapeutics for conditions marked by inflammation, inflammatory pain, and blood cancers. The company was formerly known as Aquinox Pharmaceuticals (USA) Inc. and changed its name to Aquinox Pharmaceuticals, Inc. in January 2014. Aquinox Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

Corporate Governance

Aquinox Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.